TITLE

Journal of Clinical Investigation: Generating dopamine via cell therapy for Parkinson's disease

PUB. DATE
July 2012
SOURCE
Biomedical Market Newsletter;7/19/2012, Vol. 21, p1
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
The article informs that replacement of dopaminergic neurons by neural transplantation with mouse embryonic stem cells is used in treatment of Parkinson's disease.
ACCESSION #
79334370

 

Related Articles

  • Engineering neurons to treat Parkinson's disease. DeWitt, Natalie // Nature Biotechnology;Jul99, Vol. 17 Issue 7, p626 

    Describes a method for engineering unlimited quantities of dopaminergic neurons needed for transplantation studies to treat Parkinson's disease (PD). Restoration of functional dopaminergic neurons in the brains of patients with PD; Patients' inaccessibility to transplantation therapy;...

  • Could Parkinson's be cured by therapeutic closing? Tanday, Sanjay // GP: General Practitioner;4/4/2008, p14 

    The article reports on the significance of therapeutic cloning as an effective treatment for Parkinson's disease as revealed by U.S. research. Researchers observed an improvement in the condition of mice with Parkinson's after dopamine cells were grafted onto their brains. The egg cells grew...

  • Generation and Transplantation of Dopaminergic Neurons Derived from Embryonic Stem Cells. Khanna, Aparna; Swistowska, Anna Maria; Rao, Mahendra S.; Xianmin Zeng // Current Stem Cell Research & Therapy;May2007, Vol. 2 Issue 2, p139 

    Human embryonic stem cells (hESCs) can be propagated as undifferentiated cells over multiple passages and thus offer a renewable source of a wide range of cell types for use in research and cell-based therapies. Because of the important roles of dopaminergic (DA) neurons in modulating motor...

  • In Vitro Maturation of Dopaminergic Neurons Derived from Mouse Embryonic Stem Cells: Implications for Transplantation. Watmuff, Bradley; Pouton, Colin W.; Haynes, John M. // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    The obvious motor symptoms of Parkinson's disease result from a loss of dopaminergic neurons from the substantia nigra. Embryonic stem cell-derived neural progenitor or precursor cells, adult neurons and fetal midbrain tissue have all been used to replace dying dopaminergic neurons. Transplanted...

  • Functional Role of Parkin against Oxidative Stress in Neural Cells. Minyoung Hwang; Ja-Myong Lee; Younghwa Kim; Dongho Geum // Endocrinology & Metabolism;Mar2014, Vol. 29 Issue 1, p62 

    Background: Parkinson disease (PD) is caused by selective cell death of dopaminergic neurons in the substantia nigra. An early onset form of PD, autosomal recessive juvenile parkinsonism has been associated with a mutation in the parkin gene. The function of parkin is known to remove misfolding...

  • Functional engraftment of human ES cell–derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Roy, Neeta S.; Cleren, Carine; Singh, Shashi K.; Yang, Lichuan; Beal, M. Flint; Goldman, Steven A. // Nature Medicine;Nov2006, Vol. 12 Issue 11, p1259 

    To direct human embryonic stem (HES) cells to a dopaminergic neuronal fate, we cocultured HES cells that were exposed to both sonic hedgehog and fibroblast growth factor 8 with telomerase-immortalized human fetal midbrain astrocytes. These astrocytes substantially potentiated dopaminergic...

  • Stem cells: the good, bad and barely in control. Carson, Christian T.; Aigner, Stefan; Gage, Fred H. // Nature Medicine;Nov2006, Vol. 12 Issue 11, p1237 

    The article reports on an important finding during the generation of dopaminergic neurons from stem cells. Robust differentiation of human embryonic stem cells (HESCs) into dopaminergic neurons was achieved by coculturing HESC-derived neural precursors with immortalized human fetal midbrain...

  • Stem cell therapy for Parkinson’s disease: where do we stand? Roybon, Laurent; Christophersen, Nicolaj; Brundin, Patrik; Li, Jia-Yi // Cell & Tissue Research;Oct2004, Vol. 318 Issue 1, p261 

    A major neuropathological feature of Parkinson’s disease (PD) is the loss of nigrostriatal dopaminergic neuron. Patients exhibit motor symptoms, including bradykinesia, rigidity, and tremor. Neural grafting has been reported to restore striatial dopaminergic neurotransmission and induce...

  • Dopaminergic neurons for Parkinson's therapy. Lindvall, Olle // Nature Biotechnology;Jan2012, Vol. 30 Issue 1, p56 

    The article describes a differentiation protocol which involves the conversion of human embryonic stem cells (hESC) in substantia nigra dopaminergic neurons that ameliorate Parkinson's disease in animal models without tumor formation. This protocol produces large numbers of transplantable...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics